OXA-679

........10........20........30........40........50........60........70........80........90.......100.......110.......120.......130.......140.......150.......160.......170.......180.......190.......200.......210.......220.......230.......240.......250.......260.......270...... MRTRLFPLLSISISIFLSACSSPFIEPKDILPISTTDQTQQAIGSYFDEAQTQGVIVIKDGHNIDTYGNDLTRANTLYVPASTFKMLNALIGLENNKATVDEVFKWDGKKRSYSIWEKDMNLGEAMKLSAVPVYQELAKRIGVDLMQKEVKRVKFGNSNIGTKVDDFWLVGPLKITPIQEVEFADKLAHQELPFKQQVQKQVQDMLLIKEVEGNKIYAKSGWGMNVTPQVGWLTGWVEQPNGKKIAFSLNIEMKPNMPGSVRNEIALKSLKRLGII

OXA-730	.................................................................................................................................................................I..................................................................................................................	99.64 %
OXA-946	...........................................................................................................................................................................................................................................................K........................	99.64 %
OXA-947	........-................G..................................DQD.............Q....................................................................................P......................N.......................D..D...........................................................K....	96.01 %
OXA-948	.........................A........AIKLS..T..T................Q...S..........Q.....................................M...........................L.................................................................D..D...........................................................H....	94.20 %
OXA-949	..KN....-................G.........IK.S........N.............Q..............Q.....................................M...........................L..........D..................................YR.....L............D..D...........................................................K....	93.12 %
OXA-1051	.........G...............G..........KLS..T.....N.............Q..............Q.................................................................L..........D...........E.......................E...................................................................S.............Q....	94.57 %

Last updated: January 08, 2024.

If you use BLDB please cite: Naas, T.; Oueslati, S.; Bonnin, R. A.; Dabos, M. L.; Zavala, A.; Dortet, L.; Retailleau, P.; Iorga, B. I., Beta-Lactamase DataBase (BLDB) – Structure and Function. J. Enzyme Inhib. Med. Chem. 2017, 32, 917-919.

The development of the BLDB database is funded in part by the JPIAMR transnational project DesInMBL, the Région Ile-de-France (DIM Malinf) and the Laboratory of Excellence in Research on Medication and Innovative Therapeutics (LERMIT).

Contact: contact@bldb.eu

Live statistics (since December 3rd, 2023)